NovaBay Pharmaceuticals News

NovaBay Pharmaceuticals | DEFA14A: Others

Oct 29 20:23

NovaBay Pharmaceuticals | 8-K: Current report

Oct 29 20:18

NovaBay Pharmaceuticals | 8-K: Current report

Oct 17 04:28

NovaBay Pharmaceuticals | DEFM14A: Definitive proxy statement relating to merger or acquisition

Oct 17 04:23

NovaBay Pharmaceuticals | PREM14A: Preliminary proxy statements relating to merger or acquisition

Sep 26 05:20

NovaBay Pharmaceuticals | DEFA14A: Others

Sep 20 20:12

NovaBay Pharmaceuticals | 8-K: Current report

Sep 20 20:12

NovaBay Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 14 04:15

NovaBay Pharmaceuticals | 8-K: Current report

Jul 30 04:30

NovaBay Pharmaceuticals | 424B4: Prospectus

Jul 30 00:39

NovaBay Pharmaceuticals | POS EX: Post-effective amendment filed solely to add exhibits to a registration statement

Jul 27 05:24

NovaBay Pharmaceuticals | EFFECT: Others

Jul 26 18:09

NovaBay Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 26 00:39

NovaBay Pharmaceuticals | CORRESP: CORRESP

Jul 23 10:17

NovaBay Pharmaceuticals | CORRESP: CORRESP

Jul 23 10:17

NovaBay Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 16 00:44

NovaBay Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jul 11 20:53

NovaBay Pharmaceuticals | 8-K: Current report

Jul 11 20:48

NovaBay Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jul 11 04:10

NovaBay Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 10 21:34